Financial Tearsheet

Company Overview

Recent Financial News

Date   Headline
Dec 05, 2019 MiOXSYS Male Infertility Test Will be Featured in Product Symposium at the 8th Annual Congress of the German Federation of Reproductive Biology and Medicine
Dec 03, 2019 Aytu BioScience to Present at LD Micro 12th Annual Main Event Investor Conference on December 11, 2019
Dec 02, 2019 Aytu BioScience Announces Launch of Natesto(R) U.S. Co-Promotion with Acerus Pharmaceuticals
Nov 19, 2019 Aytu BioScience Announces Addition of Tuzistra(R) XR to Leading Pharmacy Benefit Manager’s National Formulary
Nov 14, 2019 Aytu Reports First Quarter 2020 Financial Results

IR Contacts

Hayden IR

James Carbonara
1441 Broadway
Fifth Floor
New York, NY 10018
Office: (646)-755-7412
James@haydenir.com

Stock Performance

Today's Open 0.8217
Volume 47,313
Day Range 0.7800 - 0.8489
52 Week Range 0.6800 - 2.6100
Bid/Ask 0.7900 / 0.8000
Bid/Ask Size 200 X 200
Previous Close 0.8299
Market Cap 14.39 million
Shares Outstanding 17.98 million
Dividend/Yield 0.0000 / 0.0000%
EPS (TTM) -2.365500
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
Nov 14, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Sep 26, 2019 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
May 14, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
May 14, 2019 10-Q/A Quarterly report (Amendment) htmlhtml   pdfpdf   xbrlxbrl  
Feb 07, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

Josh Disbrow, Chairman & Chief Executive Officer

Jarrett Disbrow, Chief Operating Officer

David Green, Chief Financial Officer

Board of Directors

Josh Disbrow, Chairman & Chief Executive Officer

Gary Cantrell, Director, Chair, Compensation Committee

Carl Dockery, Director, Chair, Nominating & Governance Committee

John Donofrio, Jr., Director, Chair, Audit Committee

Michael Macaluso, Director